收藏切换
Clinical therapeutic effect of the Xuezhikang capsule combined with fluvastatin sodium on hyperlipidemia
收藏切换
Chao SHI, Xing WANG, Hong-ling ZHU*
World Clinical Drug | 2018, 39(1) : 43 - 46
Less
收藏切换
World Clinical Drug | 2018, 39(1): 43-46
• Article •
Clinical therapeutic effect of the Xuezhikang capsule combined with fluvastatin sodium on hyperlipidemia
Full
Chao SHI, Xing WANG, Hong-ling ZHU*
Affiliations
  • Department of Endocrine and Metabolism, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, China
Published: 2018-01-10 doi: 10.13683/j.wph.2018.01.009
Outline
收藏切换
Objective

To investigate the clinical efficacy and safety of the Xuezhikang capsule combined with fluvastatin sodium on hyperlipidemia.

Methods

A total of 124 patients with hyperlipidemia were randomly divided into the observation group and the control group, with 62 cases in each group. The control group was given fluvastatin sodium (40 mg/time, once daily), the observation group was additionally taken Xuezhikang capsule (0.6 g/time, twice daily), and the treatment time was 8 weeks. The serum lipid levels [total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and highdensity lipoprotein cholesterol (HDL-C)] and C reactive protein (CRP) levels] before and after 4 and 8 weeks treatment, and hemorheology indexes (high shear whole blood viscosity, low shear whole blood viscosity, plasma viscosity, hematocrit and fibrinogen) before and after treatment, and the efficacy and adverse drug reactions were observed and compared.

Results

The total effective rate of the observation group (85.48%) was higher than that of the control group (69.35%, P<0.05). Compared with before treatment, the serum TC, TG, LDL-C and the CRP after 4 and 8 weeks treatment of both two groups were decreased, and the HDL-C was increased (P<0.05). Compared with control group, the serum lipid level of observation group was improved more significantly (P<0.05). Compared with before treatment, the hemorheology indexes of two groups after treatment were decreased; the plasma viscosity, hematocrit and fibrinogen of observation group were lower than those of control group (P<0.05).

Conclusion

Xuezhikang capsule combined with fluvastatin sodium can obviously improve blood lipid levels and reduce CRP level in hyperlipidemia treatment.

Xuezhikang capsule  /  fluvastatin sodium  /  hyperlipidemia  /  therapeutic effect
施超, 王星, 朱鸿玲. 血脂康胶囊联合氟伐他汀钠治疗高脂血症的临床观察. 世界临床药物, 2018 , 39 (1) : 43 -46 . DOI: 10.13683/j.wph.2018.01.009
Chao SHI, Xing WANG, Hong-ling ZHU. Clinical therapeutic effect of the Xuezhikang capsule combined with fluvastatin sodium on hyperlipidemia[J]. World Clinical Drug, 2018 , 39 (1) : 43 -46 . DOI: 10.13683/j.wph.2018.01.009
Year 2018 volume 39 Issue 1
14
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2018.01.009
  • Receive Date:2017-09-14
  • Online Date:2026-11-19
  • Published:2018-01-10
Article Data
Affiliations
History
  • Received:2017-09-14
  • Revised:2017-12-01
Funding
Affiliations
    Department of Endocrine and Metabolism, Shanghai Pudong New Area Gongli Hospital, Shanghai 200135, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.01.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT